Search Results

Results for "T"

Upcoming Rare Disease Workshop Focuses on the Importance of Data Sharing in Drug Development

C-Path, NORD and FDA to host annual workshop September 13-14 to highlight the impact of their innovative data and analytics platfo

Four PKD Reports Published in CJASN

C-Path and PKDOC are excited to announce that four reports summarizing Sessions 1, 2, and 3B from the 2021 PKD Regulatory Summit h

August 16, 2022

Current Challenges and Perspectives on Developing a Clinical Trial Design for ADPKD

Autosomal dominant polycystic kidney disease (ADPKD) is a major genetic disorder affecting up to 12 million individuals worldwide

C-Path to Lead Pre-Consortium Aimed at Transforming, Accelerating Medical Product Development in Lysosomal Diseases

TUCSON, Ariz., Sept. 1, 2022 — Critical Path Institute (C-Path) today announced the launch of a pre-consortium collaboration foc

C-Path’s Kristen Swingle Named President

Swingle joined C-Path in 2019 and was named interim president in 2021 TUCSON, Ariz., Sept. 8, 2022 — Critical Path Institute (C-

C-Path Awarded FDA Grant to Establish Public-Private Partnership to Advance Treatments for Rare Neurodegenerative Diseases

TUCSON, Ariz., Sept. 14, 2022 — Critical Path Institute (C-Path) has announced it will serve as the convener of the Critical Pat

Rare Disease Workshop Highlights the Importance of Data Sharing in Drug Development

C-Path, NORD and FDA hosted an annual workshop September 13-14 to spotlight the impact of their innovative data and analytics plat

C-Path’s European Nonprofit Appoints Managing Director and New Board Member to Expand Global Efforts

TUCSON, Ariz. and AMSTERDAM, September 20, 2022 — Critical Path Institute’s (C-Path) European nonprofit today announced the ap

Global Biopharmaceutical Leader to Usher C-Path in Next Phase of Growth and Innovation

Board names Dr. Daniel Jorgensen as Chief Executive Officer TUCSON, Ariz., Sept. 27, 2022 — Critical Path Institute (C-Path) tod

October 29, 2022

View Now | The Role of Integrated Datasets in Addressing Rare Diseases Research Challenges

Gaining knowledge on rare diseases is limited by the scarcity and dispersity of patient data. Sequencing technologies have greatly

Previous1718 19...132 Next